2022 financial year, Early 2023 and outlook
30 March 2023
Completion of financing operations for the 2023-2024 strategic plan
27 February 2023
METabolic EXplorer secures financing for deployment of its strategy
27 December 2022
2022 half-year results and provision of the half-year financial report
30 September 2022
Q2 2022 consolidated revenue: €62.2m
28 July 2022
Update on the situation
29 June 2022
Financial information Q1 2022
5 May 2022
METEX NØØVISTAGO starts selling the INNEUS® range for animal welfare and health
19 April 2022
Signing of a Term Sheet for €100 million worth of syndicated financing to support the Group’s growth
7 April 2022
2021 annual results
31 March 2022